Today: 20 May 2026
Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next
4 January 2026
1 min read

Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

NEW YORK, Jan 4, 2026, 11:12 ET — Market closed

  • GWRE slid sharply on the first trading day of 2026, leaving the stock on watch for a technical reset into Monday.
  • Investors are still digesting Guidewire’s raised fiscal-year outlook from December, with ARR and cloud momentum in focus.
  • The next catalysts include U.S. jobs and inflation data this week and Guidewire’s next earnings window in early March.

Guidewire Software, Inc. shares closed down 6.7% on Friday at $187.63 and last traded around $189 in after-hours activity.

That drop pushed GWRE well below its 50-day and 200-day moving averages — roughly $215 and $220 — levels derived from past prices that many traders use as trend markers. Its 14-day relative strength index, a momentum gauge, sat near 30, a reading often associated with “oversold” conditions.

The move came as U.S. stocks ended mixed and Treasury yields climbed in a session marked by uneven participation after the New Year’s holiday. “Today is kind of a holiday trading day, lighter volumes,” said Jed Ellerbroek, a portfolio manager at Argent Capital in St. Louis. Reuters

Guidewire traded between $187.54 and $200.92 on Friday, with about 806,660 shares changing hands. The company’s market capitalization is about $16 billion and the stock is in a 52-week range of roughly $165 to $273, according to Public.com data.

Company-specific news was limited in the past two days, leaving investors anchored to the last formal update on Dec. 3, when Guidewire reported first-quarter revenue of $332.6 million, up 27%, and annual recurring revenue (ARR) — a measure of subscription value under contract — of $1.063 billion. It forecast second-quarter revenue of $339 million to $345 million and guided to fiscal 2026 ending ARR of $1.220 billion to $1.230 billion.

Guidewire sells core systems software used by property-and-casualty insurers to run policy administration, billing and claims, and it has been pushing customers toward cloud subscriptions. That shift can make quarter-to-quarter results sensitive to the timing of large customer decisions and implementation schedules.

Sell-side analysts remain broadly constructive despite the recent pullback. StockAnalysis.com shows a “Buy” consensus and an average price target of $271.69, though targets span from $160 to $305.

Guidewire competes with a mix of vertical insurance-technology vendors and in-house development at large insurers, with deal cycles often tied to multi-year modernization programs. For traders, the stock’s break below long-term averages means it can start to trade more like a sentiment barometer than a fundamentals story in the short run.

But the downside scenario is straightforward: if cloud migrations slow, or if insurers take longer to sign and expand contracts, ARR growth and margin leverage can disappoint in a stock that still screens expensive on traditional earnings measures. Rising long-end yields can also keep pressure on software valuations.

Stock Market Today

  • Euronext Q1 2026 Sees Record Trading Volumes and 15.3% Revenue Growth
    May 20, 2026, 5:43 AM EDT. Euronext reported a record Q1 2026 with cash equity trading and clearing revenue up 30.8% to €123 million, driven by high market volatility and the full contribution from Euronext Athens. Total underlying revenue rose 15.3% to €528.5 million, marking the exchange's eighth consecutive quarter of double-digit growth. Average daily cash equity transaction value in April reached €16.4 billion, with a 64.1% market share. Commodities trading revenue climbed 13.9%, while FX revenue grew 5.8%. ETF trading surged 84% since September 2025, boosted by the launch of mini ETF options. Adjusted EBITDA rose 16.7% to €343.2 million, with net income up 17.7%. Euronext declared a €3.18 dividend per share, reflecting a 50% payout, payable in May.

Latest articles

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

20 May 2026
New York, May 20, 2026, 05:08 EDT Co-Diagnostics shares face an early test on Wednesday after the diagnostic-test developer announced a $3 million private placement hours after its stock closed up 43.8% at $1.97 on Tuesday. Extended-hours trading showed the shares down 13.3% at $1.71 before the regular Nasdaq session. The timing matters. Co-Diagnostics had rallied after saying it had completed a strategy to develop an assay, or diagnostic test, for the Bundibugyo virus behind a fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda. The late financing then shifted attention to dilution and cash needs. The company said
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly
Previous Story

ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly

Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Next Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Go toTop